Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
Condition(s):B Cell Lymphoma; Lymphoma; Lymphoma, B-Cell; Diffuse Large B Cell Lymphoma; High-grade B-cell LymphomaLast Updated:January 29, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):B Cell Lymphoma; Lymphoma; Lymphoma, B-Cell; Diffuse Large B Cell Lymphoma; High-grade B-cell LymphomaLast Updated:January 29, 2024Recruiting
Condition(s):Lymphoma, Non-HodgkinLast Updated:June 11, 2020Completed
Condition(s):Lymphoma, Non-Hodgkin; Advanced Stage Diffuse Large B-Cell Non-Hodgkin’s LymphomaLast Updated:July 22, 2021Unknown status
Condition(s):Diffuse Large B-cell LymphomaLast Updated:May 12, 2017Unknown status
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:February 28, 2024Active, not recruiting
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:September 11, 2023Completed
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:August 5, 2022Active, not recruiting
Condition(s):Diffuse Large B-cell Lymphoma; de Novo DLBCL; DLBCL Transformed From Indolent Lymphoma; Follicular Grade 3 LymphomaLast Updated:November 19, 2021Completed
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:September 19, 2019Unknown status
Condition(s):Diffuse Large B Cell Lymphoma Refractory; Diffuse Large B-cell Lymphoma RecurrentLast Updated:December 7, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.